EFM
CLVS

E Fund Management’s Clovis Oncology, Inc. CLVS Stock Holding History

E Fund Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-43,630
Closed -$118K – 371
2021
Q4 		$118K Buy
43,630
+4,095
+10% +$15.1K ﹤0.01% 282
2021
Q3 		$176K Buy
+39,535
New +$190K 0.01% 238
2021
Q1 		$164K Buy
+23,343
New +$157K 0.01% 221

Other funds holding CLVS

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

E Fund Management's CLVS Position: Q1 2022 in Review

E Fund Management sold out of Clovis Oncology, Inc. (CLVS) in Q1 2022, closing a stake of 43,630 shares — an estimated $118K sold.

E Fund Management first reported a position in CLVS in Q1 2021 and held it in 3 quarters. The position peaked at $176K in Q3 2021. 153 funds tracked by Wall St. Rank hold CLVS as of Q1 2022.

  • E Fund Management reported no remaining Clovis Oncology, Inc. position as of Q1 2022 after selling out during the quarter.
  • E Fund Management sold 43,630 Clovis Oncology, Inc. shares in Q1 2022, an estimated $118K.
  • E Fund Management first reported a position in Clovis Oncology, Inc. in Q1 2021 and held it in 3 quarters.
  • E Fund Management's Clovis Oncology, Inc. position peaked at $176K in Q3 2021.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2022.

Based on E Fund Management's 13F filing for Q1 2022, filed 12 May 2022.